Recent Activities - 2018
NRL is redesignated as a WHO Collaborating Centre
NRL has been designated as a WHO Collaborating Centre for Diagnostics and Laboratory Support for HIV/AIDS and Other Blood-borne Infections since 1985 and in November 2018, was again redesignated as a Collaborating Centre until 2022. NRL’s work supports WHO’s mission to improve the quality and safety of medicines and other health technologies through standards and guidelines, strengthening of regulatory systems, and prequalification of reagents. NRL indirectly supports WHO’s programmes to manage and administer access to medicines and other health technologies and the strengthening of regulatory capacity.
The Terms of Reference include:
To collaborate and/or organize jointly with WHO training for laboratory and health care staff in the area of quality assurance, monitoring proficiency through External Quality Assessment Schemes (EQAS) and quality management systems of testing services for WHO priority diseases such as HIV, hepatitis B, hepatitis C and Syphilis
At WHO’s request hold and maintain repositories of relevant specimens for the laboratory assessment of HIV/AIDS, hepatitis B, hepatitis C and Syphilis diagnostics technologies for WHO prequalification
When requested by WHO, act as a reference laboratory on HIV/AIDS and other blood borne infectious diseases, and a source of technical information and expertise to WHO and staff of regulatory authorities regarding the performance of related in-vitro diagnostics
NRL has a number of activities planned for 2019 and looks forward to another successful year working closely with the WHO.